Showing results (21-30 of 137) with videos related to
Sort By:
Pageof 14
Arthritis and Rheumatism|September 5, 2002
Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differencesS Louis Bridges, Grace Jenq, Molly Moran, et al.The Journal of Rheumatology|August 17, 2013
Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritisAshutosh Tamhane, David T Redden, Gerald McGwin, et al.Frontiers in Immunology|September 26, 2019
Disruption of the preB Cell Receptor Complex Leads to Decreased Bone MassMohamed Khass, Harunur Rashid, Peter D Burrows, et al.BMC Bioinformatics|January 4, 2018
Repositioning drugs by targeting network modules: a Parkinson's disease case studyZongliang Yue, Itika Arora, Eric Y Zhang, et al.Arthritis Care & Research|September 29, 2021
Association of Disease Activity and Disability With Rehabilitation Utilization in African American Adults With Rheumatoid ArthritisLouise M Thoma, Rebecca J Cleveland, Beth L Jonas, et al.Frontiers in Rehabilitation Sciences|October 3, 2022
Osteoarthritis Progression: Mitigation and Rehabilitation StrategiesDevin Drummer, Jeremy McAdam, Regina Seay, et al.Arthritis Care & Research|April 25, 2022
Associations of Socioeconomic Status With Disease Progression in African Americans With Early Rheumatoid ArthritisEmma M Astrike-Davis, Rebecca J Cleveland, S Louis Bridges, et al.The Journal of Rheumatology|November 3, 2018
HLA-DRB1 Amino Acid Positions and Residues Associated with Antibody-positive Rheumatoid Arthritis in Black South AfricansNimmisha Govind, Richard J Reynolds, Bridget Hodkinson, et al.HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|November 8, 2023
Muscle Inflammation Susceptibility: A Potential Phenotype for Guiding Precision Rehabilitation After Total Hip Arthroplasty in End-Stage OsteoarthritisS Louis Bridges, Dongmei Sun, Zachary A Graham, et al.Arthritis Research & Therapy|September 19, 2021
HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RAWilliam Rigby, Jane H Buckner, S Louis Bridges, et al.Pageof 14